Immunic, Inc. (IMUX)

Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $156.56 million. The enterprise value is $141.65 million.

Market Cap	156.56M
Enterprise Value	141.65M

Important Dates

The last earnings date was Thursday, February 26, 2026, before market open.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Immunic has 130.46 million shares outstanding. The number of shares has increased by 55.42% in one year.

Current Share Class	130.46M
Shares Outstanding	130.46M
Shares Change (YoY)	+55.42%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	1.33%
Owned by Institutions (%)	46.49%
Float	121.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.75

Current Ratio	0.75
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -1,653.15% and return on invested capital (ROIC) is -967.50%.

Return on Equity (ROE)	-1,653.15%
Return on Assets (ROA)	-198.76%
Return on Invested Capital (ROIC)	-967.50%
Return on Capital Employed (ROCE)	1,572.16%
Weighted Average Cost of Capital (WACC)	12.32%
Revenue Per Employee	n/a
Profits Per Employee	-$1.08M
Employee Count	90
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.35% in the last 52 weeks. The beta is 1.48, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.48
52-Week Price Change	+4.35%
50-Day Moving Average	0.85
200-Day Moving Average	0.81
Relative Strength Index (RSI)	59.17
Average Volume (20 Days)	3,498,122

Short Selling Information

The latest short interest is 7.58 million, so 5.81% of the outstanding shares have been sold short.

Short Interest	7.58M
Short Previous Month	6.62M
Short % of Shares Out	5.81%
Short % of Float	6.26%
Short Ratio (days to cover)	1.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-103.23M
Pretax Income	-97.17M
Net Income	-97.17M
EBITDA	-103.06M
EBIT	-103.23M
Earnings Per Share (EPS)	-$0.62

Balance Sheet

The company has $15.48 million in cash and $577,000 in debt, with a net cash position of $14.91 million or $0.11 per share.

Cash & Cash Equivalents	15.48M
Total Debt	577,000
Net Cash	14.91M
Net Cash Per Share	$0.11
Equity (Book Value)	-6.67M
Book Value Per Share	-0.06
Working Capital	-7.75M

Cash Flow

In the last 12 months, operating cash flow was -$85.81 million and capital expenditures -$161,000, giving a free cash flow of -$85.97 million.

Operating Cash Flow	-85.81M
Capital Expenditures	-161,000
Free Cash Flow	-85.97M
FCF Per Share	-$0.66

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-55.42%
Shareholder Yield	-55.42%
Earnings Yield	-62.07%
FCF Yield	-54.91%

Analyst Forecast

The average price target for Immunic is $4.25, which is 254.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.25
Price Target Difference	254.17%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1